Peramivir News
Drugs
> PeramivirPeramivir News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
- BioCryst Pharmaceuticals prices public offering of common stock 20 Nov 2009 18:59 GMT
... Financial Deals Tracker via COMTEX) -- BioCryst Pharmaceuticals, Inc., a US-based biotechnology company that designs and develops novel small-molecule ... BCX-4208 and pre-commercialization activities relating to i.v. peramivir and forodesine. Offer Price ($ per share) ...
- BioCryst prices stock offering at $9.75 per share 20 Nov 2009 15:30 GMT
... BIRMINGHAM, Ala. (AP) -- Flu drug developer BioCryst Pharmaceuticals Inc. priced its 5 ... percent. BioCryst's most advanced drug candidate is peramivir, a flu drug intended to be given ... Peramivir has been approved as an emergency treatment for swine flu, but clinical testing against ...
- BioCryst sets share price for stock offering 20 Nov 2009 18:11 GMT
... a $9.75 per share price. The Birmingham-based biotech firm initially announced the offering on Tuesday. ... of positive developments from its lead experimental drug, Peramivir, this fall that will bring in more ...
- BioCryst Announces Pricing of Public Offering of Common Stock 20 Nov 2009 02:10 GMT
... BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: ) today announced the pricing ... novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a ... T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and ...
- BioCryst prices stock offering at $9.75 per share 20 Nov 2009 16:03 GMT
... rise almost 15 percent. BioCryst's most advanced drug candidate is peramivir, a flu drug intended to be given ... Peramivir has been approved as an emergency treatment for swine flu, but clinical testing against ...
- BioCryst Announces Pricing of Public Offering of Common Stock 20 Nov 2009 02:15 GMT
... and accompanying prospectus as indicated above. BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals ... novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a ... T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and ...
- BioCryst Announces Pricing of Public Offering of Common Stock (PRN) 20 Nov 2009 02:30 GMT
... designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious ... novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for influenza, and forodesine, a ... T-cell lymphoma (CTCL). Utilizing crystallography and structure-based drug design, BioCryst continues to discover additional compounds and ...
- Experimental swine flu drug used on boy 19 Nov 2009 01:52 GMT
... China Post news staff Experimental swine flu drug used on boy TAIPEI, Taiwan -- The ... TAIPEI, Taiwan -- The experimental intravenous drug, Peramivir, was immediately released to National Taiwan University ... are unable to receive other methods of treatment. Such is the case of the ten-year-old ...
- Student Survives Bout With H1N1 19 Nov 2009 05:14 GMT
... nearly killed him. Chris Dekker said his medical ordeal started with a headache and fever ... began to chance after an experimental flu drug called Peramivir became available. Chris Dekker was the first ...
- Women dies of swine flu, becoming 48th fatality in Israel 16 Nov 2009 14:11 GMT
... to treat the woman with the experimental drug Peramivir. Israel only recently bought the drug, and ... the patient suffers from serious symptoms. The treatment was unsuccessful and the woman died several ...
- Woman dies of swine flu as virus' death toll in Israel reaches 48 16 Nov 2009 14:53 GMT
... to treat the woman with the experimental drug Peramivir. Israel only recently bought the drug, and ... the patient suffers from serious symptoms. The treatment was unsuccessful and the woman died several ...
- Novartis: lower dose of flu vaccine sufficient 17 Nov 2009 13:33 GMT
... and the strongest evidence yet that such drugs save lives. A single intravenous dose of ... single intravenous dose of the experimental drug, peramivir, cleared up flu symptoms as well as ... a study in Asia found. An IV treatment is badly needed because many sick people ...
- BioCryst's flu drug remedying years of frustration 15 Nov 2009 12:56 GMT
... news from The Birmingham News BioCryst's flu drug remedying years of frustration BioCryst CEO Jon ... company. The order for 10,000 dosages of peramivir reaped the company $22.5 million in revenue ... of BioCryst's clinical expertise, crossing into the treatment of other diseases. Work overseas is progressing ...
- Human Genome sees FDA delay with anthrax treatment 16 Nov 2009 17:34 GMT
... Human Genome sees FDA delay with anthrax treatment BioCryst Pharmaceuticals Inc. said Thursday it will ... Human Services over the intravenous flu treatment peramivir. The company said it shipped about 10,000 ... the treatment Wednesday. Peramivir is an intravenous drug intended to treat the flu in patients ...
- BioCryst sees healthy future after flu drug 16 Nov 2009 05:32 GMT
... Jon Stonehouse is seeking life beyond Peramivir. Recent revenue announcements topping $100 million have ... financial cushion required to identify the next drugs to put in the firm’s development pipeline. Peramivir ... hospitalized infants or certain adults with the flu who can’t receive drugs through other methods. ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
- FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, R [20 Nov 2009 - 17:02]
- Treatment With Folic Acid, Vitamin B12 Associated With Increased Risk Of Cancer, Death [20 Nov 2009 - 10:45]
- Two arrested, oxycodone seized after warrant search [20 Nov 2009 - 06:31]
- Folic Acid Fortification Might Boost Cancer Risk [20 Nov 2009 - 04:59]
- Morphine May Help Tumors Spread in Cancer Patients [20 Nov 2009 - 04:59]
- I Was On Fentanyl 1600mcg Lozenges For 3 Years [20 Nov 2009 - 18:02]
- FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, R [20 Nov 2009 - 17:02]
- Questions and answers on the recommendation for the refusal of a change to the marketing authorisation for Avastin [20 Nov 2009 - 16:59]
- Committee For Medicinal Products For Human Use Summary Of Positive Opinion For Temozolomide Teva [20 Nov 2009 - 16:59]
- Committee For Medicinal Products For Human Use Post-Authorisation Summary Of Positive Opinion For Taxotere [20 Nov 2009 - 16:59]
- FDA actions in brief, November 2009 (FluMist, Cervarix, Gardasil, Fluarix, Folotyn, Micardis, Twynsta, Votrient, Mirena) [20 Nov 2009 - 17:02]
- FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, R [20 Nov 2009 - 17:02]
- Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women [20 Nov 2009 - 04:58]
- FDA Approves Gardasil for Genital Warts in Men and Boys [19 Nov 2009 - 16:02]
- Gardasil No Longer Requirement For Immigrants [18 Nov 2009 - 20:54]
Pharmaceutical Industry Today
|
a digital news provider
reuters.com:
healthday.com: